Rubedo Life Sciences
6 known investors
Rubedo Life Sciences develops therapeutics targeting aging by eliminating senescent cells to extend human healthspan. The company applies artificial intelligence and chemistry to drug discovery in the longevity and regenerative medicine space.
Investors · 6
In the news
- First Human Data for Rubedo Life Sciences' Senolytic Drug RLS-1496fightaging.org · 2026
- Rubedo Life Sciences Raises $40M in Series A Financingfinsmes.com · 2024
- Rubedo Life Sciences Closes $40M Series A Financing Led by Khosla Ventures and Ahren Innovation Capitalbusinesswire.com · 2024
- Investor News Grid - Rubedo Life Sciencesrubedolife.com · 2022
- Investors & News - Rubedo Life Sciencesrubedolife.com · 2022